eli lilly glp 1 agonist Medscape The challenge of developing oral

The hindbrain has been implicated in mediating GLP-1R effects on food intake

Despite the cancer cases recorded with the use of semaglutide, other factors may have contributed to cancer development with no association with semaglutide [129]

Zepbound also mimics GLP-1 hormone effects, which influence body fluid balance and can potentially impact tear production and evaporation

Conflicts of interest Novo Nordisk markets liraglutide for the treatment of diabetes

February 2, 2026: More Than 3,000 Lawsuits Remain in MDL Against Eli Lilly and Novo Nordisk for Their GLP-1 Drugs There are currently 3,191 pending lawsuits against the maker of Trulicity and other GLP-1 drugs